Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Azacitidine combined with Venetoclax for pre-emptive treatment of AML/MDS after allogeneic stem cell transplantation: A prospective phase II study

Lizhen Liu, Shipei Xiang, Xiaoyu Lai, Luxin Yang, Yibo Wu, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yishan Ye, Panpan Zhu, He Huang, Yi Luo

Blood (2025) 146 (Supplement 1): 1061.

https://doi.org/10.1182/blood-2025-1061

Published: 2025

Journal Articles

Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.

Blood (2025) 146 (Supplement 1): 1059.

https://doi.org/10.1182/blood-2025-1059

Published: 2025

Journal Articles

High HLA evolutionary divergence mismatch increases the risk of acute graft-versus-host disease and mortality after haploidentical hematopoietic stem cell transplantation

Ce Shi, Xiangjun Zeng, Fei Gao, Jimin Shi, Yi Luo, Jian Yu, Xiaoyu Lai, Lizhen Liu, Huarui Fu, Yishan Ye, He Huang, Yanmin Zhao

Blood (2025) 146 (Supplement 1): 584.

https://doi.org/10.1182/blood-2025-584

Published: 2025

Journal Articles

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation.

Bingqian Jiang, Jian Yu, Yanmin Zhao, Yi Luo, Huarui Fu, Xiaoyu Lai, Lizhen Liu, Yishan Ye, Congxiao Zhang, Yi Yu, Guanfang Zhang, He Huang, Jimin Shi

Blood (2025) 146 (Supplement 1): 2426.

https://doi.org/10.1182/blood-2025-2426

Published: 2025

Journal Articles

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Blood (2025) 146 (Supplement 1): 2523.

https://doi.org/10.1182/blood-2025-2523

Published: 2025

Journal Articles

Safety and activity of gene therapy with AAV8 GBA1 (LY-M001)on type I adults gaucher disease

Yishan Ye, Xueping Luo, Jingwen Li, Yixiong Chen, Qin Lin, He Huang, Weiyan Zheng

Blood (2025) 146 (Supplement 1): 6098.

https://doi.org/10.1182/blood-2025-6098

Published: 2025

Journal Articles

Allo-HCT outcomes for AML patients with NUP98 rearrangements: A study on behalf of the global committee, the ALWP and the PDWP of the EBMT

Blood (2025) 146 (Supplement 1): 4270.

https://doi.org/10.1182/blood-2025-4270

Published: 2025

Journal Articles

Protecting the epithelium and taming GVHD

Yishan Ye, Mohamad Mohty

Blood (2025) 146 (8): 903–905.

https://doi.org/10.1182/blood.2025029271

Published: 2025

Journal Articles

Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Patients with Acute Myeloid Leukemia in First Remission: A Study from the Global Committee and Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 2180.

https://doi.org/10.1182/blood-2024-200423

Published: 2024

Journal Articles

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Hengwei Wu, Jimin Shi, Yi Luo, Jian Yu, Huarui Fu, Lizhen Liu, Xiaoyu Lai, Luxin Yang, Yishan Ye, Congxiao Zhang, Weijie Cao, Junjie Cao, Xiaojun Xu, Xiaoxia Hu, Ying Lu, He Huang, Yanmin Zhao

Blood (2024) 144 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2024-206823

Published: 2024

Journal Articles

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Blood (2024) 144 (Supplement 1): 7420.

https://doi.org/10.1182/blood-2024-209418

Published: 2024

Journal Articles

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Blood (2024) 144 (Supplement 1): 7418.

https://doi.org/10.1182/blood-2024-206153

Published: 2024

Journal Articles

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2024) 144 (Supplement 1): 2171.

https://doi.org/10.1182/blood-2024-212040

Published: 2024

Journal Articles

Similar Transplant Outcomes for Haplo and MUD Allo-Hcts in AML Patients Achieving CR2: A Study Analyzing 4030 Allo-HCT Recipients from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2024) 144 (Supplement 1): 3562.

https://doi.org/10.1182/blood-2024-200458

Published: 2024

Journal Articles

Combined Single-Cell and Spatial Transcriptomics Reveals the Cellular Landscape of Bronchiolitis Obliterans Syndrome in Chronic Graft-Versus-Host Disease Mouse Model

Xiaolin Yuan, Lingbo Yi, Yibo Wu, Yishan Ye, Luxin Yang, Panpan Zhu, Zhiyang Yuan, He Huang, Shanshan Pei, Yi Luo

Blood (2024) 144 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2024-209886

Published: 2024

Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Blood (2024) 144 (Supplement 1): 97.

https://doi.org/10.1182/blood-2024-204703

Published: 2024

Journal Articles

Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation during the Omicron Wave: A Single-Center Study

Panpan Zhu, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Jimin Shi, Yanmin Zhao, Jian Yu, Huarui Fu, Yishan Ye, Yibo Wu, He Huang, Yi Luo

Blood (2023) 142 (Supplement 1): 7111.

https://doi.org/10.1182/blood-2023-179826

Published: 2023

Journal Articles

Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial

Biqi Zhou, Jia Chen, Tianhui Liu, Yanming Zhang, Yishan Ye, Yiyang Ding, Mingqing Zhu, Xiao Ma, Xiaoli Li, Zhihong Lin, He Huang, Yang Xu, Depei Wu

Blood (2023) 142 (Supplement 1): 1041.

https://doi.org/10.1182/blood-2023-180993

Published: 2023

Journal Articles

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 4986.

https://doi.org/10.1182/blood-2023-185685

Published: 2023

Journal Articles

Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Blood (2023) 142 (Supplement 1): 660.

https://doi.org/10.1182/blood-2023-185557

Published: 2023

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Azacitidine combined with Venetoclax for pre-emptive treatment of AML/MDS after allogeneic stem cell transplantation: A prospective phase II study

Better outcomes with haploidentical than matched sibling donors for adult AML patients allo-transplanted in CR with detectable MRD: A study from the global committee and the ALWP of the EBMT.

High HLA evolutionary divergence mismatch increases the risk of acute graft-versus-host disease and mortality after haploidentical hematopoietic stem cell transplantation

Luspatercept in patients with hematological diseases who have delayed erythroid recovery after allogeneic hematopoietic stem cell transplantation.

Allogeneic hematopoietic cell transplantation in TP53-mutated Acute Myeloid Leukemia patients with active disease: A study from the global committee and the acute leukemia working party of the EBMT

Safety and activity of gene therapy with AAV8 GBA1 (LY-M001)on type I adults gaucher disease

Allo-HCT outcomes for AML patients with NUP98 rearrangements: A study on behalf of the global committee, the ALWP and the PDWP of the EBMT

Protecting the epithelium and taming GVHD

Better Outcome Following Younger Haploidentical Donor Versus Older Matched Unrelated Donor Transplant for Patients with Acute Myeloid Leukemia in First Remission: A Study from the Global Committee and Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

A Multicenter Randomized Controlled Trial of Low-Dose Ruxolitinib for Gvhd Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplantation

Long-Term Follow-up of Sequential Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients Achieving MRD-Negative CR after CAR-T Therapy

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Easix Score Predicts Overall Survival and Non-Relapse Mortality in Elderly Patients Undergoing Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation

Similar Transplant Outcomes for Haplo and MUD Allo-Hcts in AML Patients Achieving CR2: A Study Analyzing 4030 Allo-HCT Recipients from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Combined Single-Cell and Spatial Transcriptomics Reveals the Cellular Landscape of Bronchiolitis Obliterans Syndrome in Chronic Graft-Versus-Host Disease Mouse Model

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation during the Omicron Wave: A Single-Center Study

Haploidentical Hematopoietic Cell Transplantation Combined with an Unrelated Cord Blood Unit for Adult Acute Myeloid Leukemia Results in Improved Survival Compared to Haploidentical Hematopoietic Cell Transplantation: Results of a Multicenter, Randomized, Phase III Trial

A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Comparative Study for Haplo, MSD and MUD Allo-Hcts for AML Patients with KMT2A Rearrangement: A Study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only